Available to sourceHuman Prescription DrugGastrointestinal

Potassium Phosphates

Active ingredients · Dibasic Potassium Phosphate, Monobasic Potassium Phosphate

236 mg/mL / 224 mg/mL · Injection

By Cipla USA Inc.

NDC: 69097-055
Route: Intravenous
Therapeutic class: Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative , Osmotic Laxative , Potassium Compounds [CS], Potassium Compounds [CS], Potassium Salt , Potassium Salt
Marketing category: ANDA

Additional information

Full prescribing information for this product is available on request. Submit a sourcing request and our team will share lot details, dating, and current pricing.